Clonidine formulation in a polyorthoester carrier
US-2015374665-A1 · Dec 31, 2015 · US
US8969397B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8969397-B2 |
| Application number | US-70126110-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 5, 2010 |
| Priority date | Oct 22, 2004 |
| Publication date | Mar 3, 2015 |
| Grant date | Mar 3, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are systems and methods for contributing to the local treatment of pain. More specifically, the disclosed systems and methods contribute to the local treatment pain by inhibiting the NFκB family of transcription factors.
Opening claim text (preview).
What is claimed is: 1. A method of treating pain comprising: administering one or more depots containing clonidine and a statin locally to a target tissue site causing pain in a patient in need thereof to inhibit pro-inflammatory cytokines associated with pain, wherein the pain comprises at least one of acute pain, neuropathic pain, pain from sciatica, or radicular pain. 2. A method according to claim 1 wherein said one or more depots comprise a biodegradable…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.